An update on stem cell therapy for Asherman syndrome.

Area of Science:

• Regenerative Medicine
• Gynecology
• Stem Cell Biology

Background:

• Asherman syndrome, characterized by intrauterine adhesions, presents limited and ineffective treatment options.
• The advent of stem cell therapy offers a novel approach for managing Asherman syndrome.
• This review focuses on recent evidence regarding stem cells for Asherman syndrome treatment.

Purpose of the Study:

• To summarize recent evidence on stem cell therapy for Asherman syndrome.
• To evaluate the efficacy of stem cells in improving fertility and reducing fibrosis.
• To explore different stem cell origins and administration methods.

Main Methods:

• Review of preclinical studies in mice and clinical trials in humans.
• Analysis of various stem cell sources, including bone marrow, menstrual, umbilical cord, and adipose tissue.
• Comparison of different administration routes, such as systemic injection versus intrauterine injection.

Main Results:

• Stem cells demonstrate regenerative capacity, improving fertility and fibrosis in Asherman syndrome.
• Systemic stem cell injection proved more effective than intrauterine injection in preclinical models.
• Bone marrow-derived stem cells showed greater efficacy in uterine regeneration compared to uterine-derived stem cells.
• Clinical trials indicate safety and effectiveness of various stem cells in restoring menstruation, fertility, and endometrial regeneration.

Conclusions:

• Stem cell therapy holds significant potential as a novel treatment for Asherman syndrome.
• The regenerative properties of stem cells offer improved outcomes for patients.
• Further research into optimal stem cell types and delivery methods is warranted.